VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

Texas MPN Workshop 2022 | Calreticulin-directed vaccines how they may impact MPN treatment

Jean-Jacques Kiladjian, MD, PhD, Saint-Louis Hospital & Paris Diderot University, Paris, France, discusses the potential of calreticulin-directed vaccines in the treatment of myeloproliferative neoplasms (MPNs). Prof. Kiladjian first explains the mechanism of action of these vaccines and then goes on to explain the need to further explore their potential application in the field. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.

Disclosures

Advisory boards for Novartis, Abbvie, BMS, AOP Orphan.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter